Curie.Bio
Highly Engaged Employees
Business Services · United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
United StatesWebsite
curie.bioRevenue
<$5 MillionIndustry
About Curie.Bio
Curie.Bio Org Chart
Is Curie.Bio your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on Curie.Bio recently announced quarterly report
Check out if Curie.Bio is spiking on competitors!
Curie.Bio, which may be a good buyer, showed buying intent in Masked Content Topic
Check if Curie.Bio has recently received funding, and reach out quickly before it becomes old news!
Click to see if Curie.Bio had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at Curie.Bio
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once Curie.Bio has new funding data
Product Launch: Get notified when Curie.Bio launches new products
Website visits: Recent activity has been detected on your website
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Compare Similar Companies to Curie.Bio
Compare insights from companies similar to Curie.Bio, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Curie.Bio is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Curie.Bio is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Curie.Bio.
Curie.Bio Tech Stack
A closer look at the technologies used by Curie.Bio
Curie.Bio News & Media
Exclusive: Day after GSK buyout, IDRx chair takes new investing role at Curie.Bio
SAN FRANCISCO — Ben Auspitz, a veteran biotech investor and repeat entrepreneur, is reuniting with longtime collaborator Alexis Borisy and hisCashing in on founder-led biotech - C&EN - American Chemical Society
Scientists who want a say in the future of their inventions are once again moving from academia to the C-suiteFinance Watch: Q2 Ends, Q3 Begins With Latest Group Of VC Mega-Rounds - Scrip
Private Company Edition: June ended with Formation Bio’s $372m series D round and July began with Beacon’s $170m series B. Also, Curie.Bio raised a $380m fund, Freeflow Ventures emerged with $90m across multiple funds and EvolutionaryScale raised a $142m seed round.Curie.Bio Raises $380M Pro Rata Series A Fund To Support Portfolio Companies Through Clinical Trials
CAMBRIDGE, Mass.--(BUSINESS WIRE)--We’re excited to announce today that we have closed $380 million for our latest fund, bringing the total funds raised by Curie.Bio to nearly $1 billion. These funds will enable us to continue investing in successful early-stage therapeutics companies on their path to generating meaningful clinical data. We anticipate that the majority of this capital will be directed towards Series A rounds for clinical proof-of-concept studies, demonstrating clinical benefits
Top Business Services Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Frequently Asked Questions Regarding Curie.Bio
Curie.Bio is a founder-focused seed-stage venture firm combined with an industry-grade therapeutics accelerator focused on one thing: helping entrepreneurial founders launch viable therapeutics companies. Curie.Bio does this by giving founders access to a team of the worlds best drug hunters and drug makers, seed capital, and best-of-breed services... Read More
